BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 10925876)

  • 1. [The adsorbed-DTP-m vaccination of children with allergically altered reactivity].
    Kostinov MP; Balabolkin II; Sigaeva LA; Reutova VS; Bogatyreva EIa
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):44-9. PubMed ID: 7778374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
    Diao L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the immune response in children having different HLA phenotypes after the first revaccination with ADTP].
    Prilutskiĭ AS; Maĭlian EA; Radomskaia FS; Filippova TI; Eremin NM; Laricheva LN; Matveĭchuk LF; Klimenko TM; Karpenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):86-8. PubMed ID: 7879562
    [No Abstract]   [Full Text] [Related]  

  • 4. [The revaccination against diphtheria and tetanus with adsorbed DT-m anatoxin of children having solid tumors in their case histories].
    Karpocheva SV; Kostinov MP; Zaeva GE; Gurvich EB; Zaĭtseva LA; Gavrilova GL; Korotkova OV; Kuznetsova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):46-9. PubMed ID: 10852050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
    Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC
    Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; Redwan EM
    Hum Antibodies; 2017; 25(1-2):23-29. PubMed ID: 27858706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The characteristics of the development of immunity with a primary immunization complex using adsorbed DTP vaccine].
    Kosenkova TV; Fedorov GN; Naperstnikov VV; Grigor'eva VN; Koliasnikova IV; Stefani DV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):55-8. PubMed ID: 10925876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
    Patel SS; Wagstaff AJ
    Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.